Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report.

Authors :: Gupta M
Yamauchi PS
Bagot M
Szepietowski J
Bhatia S
Lotti T
Goldust M
Source :: Clinical case reports [Clin Case Rep] 2020 May 26; Vol. 8 (9), pp. 1647-1650. Date of Electronic Publication: 2020 May 26 (Print Publication: 2020).
Publication Year :: 2020
Abstract: Recombinant interferon beta-1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.<br />Competing Interests: None declared.<br /> (© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)

Full Text Access

Tools